Bora CDMO Bora CDMO

X

Find US Patent Information with US Patent Number, Application Number and Patent Expiration Date of Edurant on PharmaCompass.com

PharmaCompass
Related ProductsRelated Products
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

0

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
INTERMEDIATES
DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

0

South Africa

South Africa

0

Uploaded Dossiers

Uploaded Dossiers

0

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

0

USP

0

JP

0

Other Listed Suppliers

0

SERVICES

0

left grey arrow
right gray arrow
  • TABLET;ORAL - 200MG;EQ 25MG BASE;300MG
  • TABLET;ORAL - 200MG;EQ 25MG BASE;EQ 25MG BASE
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8716264
Y
2024-01-13
U-257
202123
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7125879
Y
Y
2025-04-21
U-257
202123
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8754065*PED
2033-02-15
208351
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7125879
Y
Y
2025-04-21
U-257
208351
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9457036
Y
2024-01-13
U-257
202123
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9744181
Y
2024-01-13
U-257
202123
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9296769*PED
2033-02-15
208351
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8754065
Y
Y
2032-08-15
U-257
208351
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7390791
Y
Y
2025-04-17
208351
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7390791*PED
2025-10-17
208351
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8841310
Y
2025-12-09
U-257
202123
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
8592397
Y
2024-01-13
U-257
202123
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
10857102
Y
2033-01-14
202123
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
9296769
Y
Y
2032-08-15
U-257
208351
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7125879
Y
Y
2025-04-21
U-1740
202022
IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT-NAIVE PATIENTS WITH HIV-1 RNA LESS THAN OR EQUAL TO
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7125879*PED
2025-10-21
202022
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7125879
Y
Y
2025-04-21
U-1153
202022
IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS, IS INDICATED FOR THE TREATMENT OF HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) INFECTION IN ANTIRETROV
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7125879
Y
Y
2025-04-21
U-1307
202022
IN COMBINATION WITH OTHER ANTIRETROVIRAL AGENTS FOR THE TREATMENT OF HIV-1 INFECTION IN TREATMENT-NAIVE ADULT PATIENTS WITH HIV-1 RNA LESS THAN OR EQU
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag U.S.A
Digital Content Digital Content
URL Supplier Web Content
7125879
Y
Y
2025-04-21
U-3353
202022
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
9242986
Y
Y
2029-12-08
210192
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8129385*PED
2028-04-05
210192
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
10426780
Y
Y
2031-01-24
U-257
210192
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
8129385
Y
Y
2027-10-05
210192
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
7125879
Y
Y
2025-04-21
U-257
210192
TREATMENT OF HIV INFECTION
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Flag United Kingdom
Digital Content Digital Content
URL Supplier Web Content
9242986*PED
2030-06-08
210192
1
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY